Guru Sonpavde
2006–2025 年に発表
- 179
- 論文数
- 20,190
- 被引用数
- 77
- h 指数
- 167
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine76.9%
- Biochemistry, Genetics and Molecular Biology15.2%
- Immunology and Microbiology4.9%
- Computer Science0.6%
- Neuroscience0.6%
- Engineering0.4%
- その他1.4%
トピック
- Bladder and Urothelial Cancer Treatments8.4%
- Cancer Immunotherapy and Biomarkers7.4%
- Inflammatory Biomarkers in Disease Prognosis4.8%
- Urinary and Genital Oncology Studies4%
- Prostate Cancer Treatment and Research3.9%
- Renal cell carcinoma treatment3.3%
- その他68.2%
共著者
- Toni K. Choueiri25
- Matthew D. Galsky23
- Neeraj Agarwal21
- Petros Grivas20
- Amin H. Nassar19
- Bradley A. McGregor18
- Jonathan E. Rosenberg18
- Noah M. Hahn17
- Joaquim Bellmunt16
- Gregory R. Pond14
- Shilpa Gupta14
- Thomas Powles14
- Andrea Necchi13
- Mehmet Asım Bilen13
- Cora N. Sternberg12
- Sumanta K. Pal12
- Yohann Loriot12
- Daniel P. Petrylak11
- Sarah Abou Alaiwi11
- Seth P. Lerner11
- Elizabeth R. Plimack10
- Nicholas J. Vogelzang10
- Thomas E. Hutson10
- Abhishek Tripathi9
全論文
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
著者: Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde, Yohann Loriot, Ignacio Durán, Jae‐Lyun Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Chunzhang Wu, Mary S. Campbell, Maria Matsangou, Daniel P. Petrylak - New England Journal of Medicine 2021 被引用: 1,155
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
著者: Arnoud J. Templeton, Mairéad G. McNamara, Boštjan Šeruga, Francisco Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz‐Amit, Guru Sonpavde, Jennifer J. Knox, Ben Tran, Ian F. Tannock, Eitan Amir - JNCI Journal of the National Cancer Institute 2014 被引用: 3,272
- Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
著者: Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles, Andrea Necchi, Mauricio Burotto, Michael Schenker, Juan Pablo Sade, Aristotelis Bamias, Philippe Beuzeboc, Jens Bedke, Jan Oldenburg, Gurkamal Chatta, Yüksel Ürün, Dingwei Ye, Zhisong He, Begoña P. Valderrama, Ja Hyeon Ku, Yoshihiko Tomita, Jeiry Filian, Lily Wang, Daniela Purcea, M. PATEL, Federico Nasroulah, Matthew D. Galsky - New England Journal of Medicine 2023 被引用: 462
- EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
著者: Jonathan E. Rosenberg, Thomas Powles, Guru Sonpavde, Yohann Loriot, Ignacio Durán, J.-L. Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Ronac Mamtani, Chunzhang Wu, Maria Matsangou, Mary S. Campbell, Daniel P. Petrylak - Annals of Oncology 2023 被引用: 153
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
著者: Pier Vitale Nuzzo, Jacob E. Berchuck, Keegan Korthauer, Sándor Spisák, Amin H. Nassar, Sarah Abou Alaiwi, Ankur Chakravarthy, Shu Yi Shen, Ziad Bakouny, Francesco Boccardo, John A. Steinharter, Gabrielle Bouchard, Catherine Curran, Wenting Pan, Sylvan C. Baca, Ji-Heui Seo, Gwo‐Shu Mary Lee, M. Dror Michaelson, Steven L. Chang, Sushrut S. Waikar, Guru Sonpavde, Rafael A. Irizarry, Mark M. Pomerantz, Daniel D. De Carvalho, Toni K. Choueiri, Matthew L. Freedman - Nature Medicine 2020 被引用: 292
- Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
著者: Matthew D. Galsky, Noah M. Hahn, Jonathan Rosenberg, Guru Sonpavde, Thomas E. Hutson, William Oh, Robert Dreicer, Nicholas J. Vogelzang, Cora N. Sternberg, Dean F. Bajorin, Joaquim Bellmunt - Journal of Clinical Oncology 2011 被引用: 688
- The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
著者: Bradley A. McGregor, Guru Sonpavde, Lucia Kwak, Meredith M. Regan, Xīn Gào, H. Hvidsten, Charlene Mantia, Xiao X. Wei, J.E. Berchuck, Stephanie Berg, Praful Ravi, M. Dror Michaelson, Toni K. Choueiri, Joaquim Bellmunt - Annals of Oncology 2023 被引用: 86
- Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
著者: Philipp Nuhn, Johann S. de Bono, Karim Fizazi, Stephen J. Freedland, Maurizio Grilli, Philip W. Kantoff, Guru Sonpavde, Cora N. Sternberg, Srinivasan Yegnasubramanian, Emmanuel S. Antonarakis - European Urology 2018 被引用: 446
- Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
著者: Guillermo de Velasco, Youjin Je, Dominick Bossé, Mark M. Awad, Patrick A. Ott, Raphael Brandão Moreira, Fabio A.B. Schutz, Joaquim Bellmunt, Guru Sonpavde, F. Stephen Hodi, Toni K. Choueiri - Cancer Immunology Research 2017 被引用: 476
- Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
著者: Vadim S. Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam, Christopher Su, Ali Raza Khaki, Chelsea K. Osterman, Michael Glover, Ryan S. Chiang, Dimitrios Makrakis, Rafee Talukder, Emily Lemke, T. Anders Olsen, Jayanshu Jain, Albert Jang, Alicia Ali, Tanya Jindal, Jonathan Chou, Terence W. Friedlander, Christopher Hoimes, Arnab Basu, Yousef Zakharia, Pedro C. Barata, Mehmet Asım Bilen, Hamid Emamekhoo, Nancy B. Davis, Sumit Shah, Matthew I. Milowsky, Shilpa Gupta, Matthew T. Campbell, Petros Grivas, Guru Sonpavde, Deepak Kilari, Ajjai Alva - Cancer 2021 被引用: 85
- Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
著者: Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh, Min Yuen Teo, Randy F. Sweis, Daniel M. Geynisman, Petros Grivas, Gurkamal Chatta, Zachery R. Reichert, Joseph W. Kim, Mehmet Asım Bilen, Bradley A. McGregor, Parminder Singh, Abhishek Tripathi, Suzanne Cole, Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Sandy Srinivas, Jiaoti Huang, Meagan Odegaard, Colleen Watt, Daniel P. Petrylak, Jeannie Hoffman-Censits, Yujia Wen, Olwen Hahn, Cecilia Mitchell, Alan W.C. Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J. Morris, Jonathan E. Rosenberg - New England Journal of Medicine 2024 被引用: 145
- Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
著者: Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Tomin Perea-Chamblee, Kodi Taraszka, Habib El‐Khoury, Muhieddine Labban, Christopher J. Fong, Kanika Arora, Chris Labaki, Wenxin Xu, Guru Sonpavde, Robert I. Haddad, Kent W. Mouw, Marios Giannakis, F. Stephen Hodi, Noah Zaitlen, Adam J. Schoenfeld, Nikolaus Schultz, Michael F. Berger, Laura E. MacConaill, Guruprasad Ananda, David J. Kwiatkowski, Toni K. Choueiri, Deborah Schrag, Jian Carrot‐Zhang, Alexander Gusev - Cancer Cell 2022 被引用: 116
- CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
著者: Elio Adib, Amin H. Nassar, Elie W. Akl, Sarah Abou Alaiwi, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Guru Sonpavde, Robert I. Haddad, Kent W. Mouw, Marios Giannakis, F. Stephen Hodi, Sachet A. Shukla, Alexander Gusev, David A. Braun, Toni K. Choueiri, David J. Kwiatkowski - Clinical Cancer Research 2021 被引用: 129
- TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling
著者: Song Gao, Shuaibin Wang, Zhiying Zhao, Chao Zhang, Zhicao Liu, Ping Ye, Zhifang Xu, Baozhu Yi, Kai Jiao, Gurudatta Naik, Shi Wei, Soroush Rais‐Bahrami, Sejong Bae, Wei‐Hsiung Yang, Guru Sonpavde, Runhua Liu, Lizhong Wang - Nature Communications 2022 被引用: 66
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
著者: Matthew D. Galsky, Noah M. Hahn, Jonathan E. Rosenberg, Guru Sonpavde, Thomas E. Hutson, William Oh, Robert Dreicer, Nicholas J. Vogelzang, Cora N. Sternberg, Dean F. Bajorin, Joaquim Bellmunt - The Lancet Oncology 2011 被引用: 345
- Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
著者: Bradley A. McGregor, Matthew T. Campbell, Wanling Xie, Subrina Farah, Mehmet Asım Bilen, Andrew Schmidt, Guru Sonpavde, Kerry L. Kilbridge, Atish D. Choudhury, Amir Mortazavi, Amishi Y. Shah, Aradhana M. Venkatesan, Glenn J. Bubley, Arlene O. Siefker‐Radtke, Rana R. McKay, Toni K. Choueiri - Cancer 2020 被引用: 112
- ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
著者: Hasibur Rehman, Darshan S. Chandrashekar, Chakravarthi Balabhadrapatruni, Saroj Nepal, Sai Akshaya Hodigere Balasubramanya, Abigail Shelton, Kasey Skinner, Ai‐Hong Ma, Ting Rao, Sumit Agarwal, Marie‐Lisa Eich, Alyncia D. Robinson, Gurudatta Naik, Upender Manne, George J. Netto, C. Ryan Miller, Chong-xian Pan, Guru Sonpavde, Sooryanarayana Varambally, James E. Ferguson - JCI Insight 2022 被引用: 65
- Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
著者: Talal El Zarif, Amin H. Nassar, Elio Adib, Bailey G. Fitzgerald, Jiaming Huang, Tarek H. Mouhieddine, P Rubinstein, Taylor K. Nonato, Rana R. McKay, Mingjia Li, Arjun Mittra, Dwight H. Owen, Robert A. Baiocchi, Michael Lorentsen, Christopher Dittus, Nazlı Dizman, Adewunmi Falohun, Noha Abdel‐Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J. Shah, Edward El‐Am, Elie Kozaily, Wassim Abdallah, Ahmad Al‐Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G. Lechner, Alexandra Drakaki, Javier Baena, Caroline A. Nebhan, Tarek Haykal, Michael A. Morse, Alessio Cortellini, David J. Pinato, Alessia Dalla Pria, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui‐Lia, Danai Dima, Ryan W. Dobbs, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina V. Long, Alexander M. Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Damé Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin Reid, Elizabeth Y. Chiao, Elad Sharon, Douglas B. Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U. Marron, Toni K. Choueiri, Lindsey R. Baden, Kathryn Lurain, Guru Sonpavde, Abdul Rafeh Naqash - Journal of Clinical Oncology 2023 被引用: 69
- Prostate Cancer, Version 1.2016
著者: James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony V. D’Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, David Raben, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2016 被引用: 655
- Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
著者: Matthew D. Galsky, G. J. Chen, William Oh, Joaquim Bellmunt, Bruce J. Roth, Roberto Petrioli, Luigi Dogliotti, Robert Dreicer, Guru Sonpavde - Annals of Oncology 2011 被引用: 290
- Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
著者: Vitaly Margulis, Mäneka Puligandla, Edouard J. Trabulsi, Elizabeth R. Plimack, Elizabeth R. Kessler, Surena F. Matin, Guilherme Godoy, Ajjai Alva, Noah M. Hahn, Michael A. Carducci, Jean Hoffman‐Censits, Nirmish Singla, Antony Ruggeri, Leslie Howard, John McCann, Scott E. Delacroix, Matthew Matthew, Yagnesh Oza, Jennifer Wang, Benjamin A. Gartrell, Maha Hussain, Marc Matrana, Sam Benjamin, Guru Sonpavde, Elaine T. Lam, Brandon Bernard, Yousef Zakharia, Sarah E. Taylor, Matthew I. Milowsky, Sofia Ghani, Sindhu Singh, Kevin M. Kane, Yull Arriaga, Amee Morgans, David D. Chism - The Journal of Urology 2019 被引用: 133
- Immune-Related Adverse Events with PD-1 Versus PD-L1 Inhibitors: A Meta-Analysis of 8730 Patients from Clinical Trials
著者: Guru Sonpavde, Petros Grivas, Yushun Lin, Daniel Hennessy, Jay D. Hunt - Future Oncology 2021 被引用: 102
- The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
著者: Gregory R. Pond, Guru Sonpavde, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, Andrew J. Armstrong - European Urology 2013 被引用: 198
- Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
著者: Sumanta K. Pal, Guru Sonpavde, Neeraj Agarwal, Nicholas J. Vogelzang, Sandy Srinivas, Naomi B. Haas, Sabina Signoretti, Bradley A. McGregor, Jeremy O. Jones, Richard B. Lanman, Kimberly C. Banks, Toni K. Choueiri - European Urology 2017 被引用: 142
